Since 2020, the Institute of Cell Therapy is a member of Cord Blood Association (CBA), the most authoritative international organization in the field of biobanking of perinatal tissues (umbilical cord blood, umbilical cord, placenta). This was preceded by a thorough inspection of Cryobank by CBA specialists: evaluation of the company’s reputation, package of services, methods, experience of clinical use of cryopreserved drugs.
The Cord Blood Association is an international non-profit organization created to promote the development of both public and private (family-type) umbilical cord blood banks. The Cord Blood Association is headed by Professor Joanne Kurtzberg from the Duke University (USA), one of the pioneers in the field of clinical use of umbilical cord blood. It was Professor Kurtzberg who performed the world’s first unrelated umbilical cord blood transplant in 1991 and initiated the use of umbilical cord blood stem cells in the treatment of autism and cerebral palsy.
In 2020, the Cord Blood Association allocated a grant of $ 225,000 for further research of the mechanism of therapeutic action of umbilical cord blood and umbilical cord stem cells in the treatment of neurological diseases in children.
A multi-center research project for a period of 2 years is planned, the purpose of which includes, inter alia, the development of standardized methods for long-term monitoring of the results of cell therapy. The clinical trial is coordinated by Duke University (USA).
The Institute of Cell Therapy is one of the largest and most technological banks of umbilical cord blood, other human tissues and cells in Eastern Europe. In 2020, the Institute of Cell Therapy initiated in Ukraine a clinical trial on the treatment of coronavirus pneumonia (COVID-19) using allogeneic cryopreserved multipotent placental stem cells according to the methodology developed by the Institute. The scientific achievements of the Institute of Cell Therapy Cryobank were appreciated by other members of the Association, which allows us to say that Ukrainian biotechnologies are on a high world level nowadays.
As a member of the Cord Blood Association, the Institute of Cell Therapy supports scientific and social projects of the organization and participates in their implementation.
On February 26, 2021, the President of the Cord Blood Association, Professor Joanne Kurtzberg, sent a letter of gratitude to the Institute of Cell Therapy for participating in and supporting the Association’s projects over the past 12 months.
The Institute of Cell Therapy thanks the Cord Blood Association for the great honor of participating in the organization’s projects and will continue to make every effort to meet the high quality requirements essential to maintain membership in the Cord Blood Association.